Clinical Trials Browser

Graft vs Host Disease × Interleukin-2 × Myeloid × Clear all

NCT01390402 2016-02-03

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Phase 2 Completed

6 enrolled 3 charts

MyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive